480 related articles for article (PubMed ID: 21313813)
1. Development and validation of a high-performance liquid chromatographic method for determination of eprosartan in bulk drug and tablets.
Patel HU; Suhagia BN; Patel CN
J AOAC Int; 2010; 93(6):1862-7. PubMed ID: 21313813
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a stability-indicating column high-performance liquid chromatographic assay method for determination of nebivolol in tablet formulation.
Kachhadia PK; Doshi AS; Joshi HS
J AOAC Int; 2008; 91(3):557-61. PubMed ID: 18567301
[TBL] [Abstract][Full Text] [Related]
3. Determination of eprosartan mesylate and hydrochlorothiazide in tablets by derivative spectrophotometric and high-performance liquid chromatographic methods.
Hacioğlu F; Onal A
J Chromatogr Sci; 2012 Sep; 50(8):688-93. PubMed ID: 22576732
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous analysis of eprosartan and hydrochlorothiazide in tablets by high-performance liquid chromatography.
Patel HU; Suhagia BN; Patel CN
Pharm Methods; 2011 Apr; 2(2):143-7. PubMed ID: 23781445
[TBL] [Abstract][Full Text] [Related]
5. Identification and determination of selected angiotensin II receptor antagonist group drugs by HPLC method.
Czerwińska K; Mazurek AP
Acta Pol Pharm; 2011; 68(6):831-7. PubMed ID: 22125946
[TBL] [Abstract][Full Text] [Related]
6. Spectral and polarographic determination of eprosartan. Kinetic studies of the oxidation of eprosartan using a platinum electrode.
El-Yazbi FA; Hammud HH; Sonji NM; Sonji GM
Pharmazie; 2008 Jun; 63(6):420-7. PubMed ID: 18604984
[TBL] [Abstract][Full Text] [Related]
7. A selective high-performance liquid chromatography method for the determination of reboxetine in bulk drug and tablets.
Onal A; Sağiri O; Cetin SM; Toker S
J AOAC Int; 2006; 89(6):1552-6. PubMed ID: 17225601
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a stability-indicating HPLC assay method for simultaneous determination of spironolactone and furosemide in tablet formulation.
Ram VR; Dave PN; Joshi HS
J Chromatogr Sci; 2012 Sep; 50(8):721-6. PubMed ID: 22641089
[TBL] [Abstract][Full Text] [Related]
9. Stability-indicating RP-HPLC method development and validation for duloxetine hydrochloride in tablets.
Patel SK; Patel NJ; Prajapati AM; Patel DB; Patel SA
J AOAC Int; 2010; 93(1):123-32. PubMed ID: 20334174
[TBL] [Abstract][Full Text] [Related]
10. Stress degradation studies and kinetic determinations of duloxetine enteric-coated pellets by HPLC.
Gomes P; Wingert NR; Paim CS; Schapoval EE; Steppe M
J AOAC Int; 2010; 93(6):1829-35. PubMed ID: 21313809
[TBL] [Abstract][Full Text] [Related]
11. A stability-indicating high performance liquid chromatographic (HPLC) assay for the simultaneous determination of atorvastatin and amlodipine in commercial tablets.
Mohammadi A; Rezanour N; Ansari Dogaheh M; Ghorbani Bidkorbeh F; Hashem M; Walker RB
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):215-21. PubMed ID: 17010681
[TBL] [Abstract][Full Text] [Related]
12. Quality by design: a systematic and rapid liquid chromatography and mass spectrometry method for eprosartan mesylate and its related impurities using a superficially porous particle column.
Kalariya PD; Kumar Talluri MV; Gaitonde VD; Devrukhakar PS; Srinivas R
J Sep Sci; 2014 Aug; 37(16):2160-71. PubMed ID: 24913516
[TBL] [Abstract][Full Text] [Related]
13. Liquid chromatographic determination of cetirizine in oral formulations.
Bajerski L; Cardoso SG; Diefenbach IF; Malesuik MD; Sílvia H; Borgmann M
J AOAC Int; 2005; 88(2):424-7. PubMed ID: 15859066
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a HPLC-UV method for the determination in didanosine tablets.
de Oliveira AM; Löwen TC; Cabral LM; dos Santos EM; Rodrigues CR; Castro HC; dos Santos TC
J Pharm Biomed Anal; 2005 Jul; 38(4):751-6. PubMed ID: 15967304
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a new HPLC-UV method for the simultaneous determination of triclabendazole and ivermectin B1a in a pharmaceutical formulation.
Shurbaji M; Abu Al Rub MH; Saket MM; Qaisi AM; Salim ML; Abu-Nameh ES
J AOAC Int; 2010; 93(6):1868-73. PubMed ID: 21313814
[TBL] [Abstract][Full Text] [Related]
16. Validated stability-indicating assay method for simultaneous determination of aceclofenac and thiocolchicoside using RP-HPLC.
Samanthula G; Shrigod VV; Patel PN
Drug Res (Stuttg); 2014 Aug; 64(8):429-35. PubMed ID: 24310363
[TBL] [Abstract][Full Text] [Related]
17. Validated stability-indicating HPLC-DAD method for determination of the recently approved hepatitis C antiviral agent daclatasvir.
Baker MM; El-Kafrawy DS; Mahrous MS; Belal TS
Ann Pharm Fr; 2017 May; 75(3):176-184. PubMed ID: 28187879
[TBL] [Abstract][Full Text] [Related]
18. Determination of olmesartan medoxomil in tablets by UV-Vis spectrophotometry.
Celebier M; Altinoz S
Pharmazie; 2007 Jun; 62(6):419-22. PubMed ID: 17663188
[TBL] [Abstract][Full Text] [Related]
19. Liquid chromatographic method for the simultaneous determination of eprosartan and hydrochlorothiazide in tablets and human plasma.
Belal F; El-Brashy AM; El-Enany N; Tolba MM
J AOAC Int; 2011; 94(3):823-32. PubMed ID: 21797010
[TBL] [Abstract][Full Text] [Related]
20. Validation of a solid phase extraction-high performance liquid chromatographic method for the determination of eprosartan in human plasma.
Ferreirós N; Iriarte G; Alonso RM; Jiménez RM; Ortíz E
J Chromatogr A; 2006 Jun; 1119(1-2):309-14. PubMed ID: 16542666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
